As doctoral students nearly 20 years ago, two Cornell researchers played an early role in the development of the work that was awarded the 2022 Nobel Prize in chemistry.
Nancy Schlichting '79 is a pioneering leader the healthcare industry, an enthusiastic supporter of the Sloan Program in Health Administration and now an honoree in the Modern Healthcare Hall of Fame.
Antibodies that summon white blood cells may play an important role in protecting infants from congenital infection with human cytomegalovirus, according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.
By the end of this century, Cornell’s Flavio Lehner and others said that megadroughts – extended drought events that can last two decades – will be more severe and longer in the western U.S. than they are today.
North American white-tailed deer – shown in 2021 surveys of five states to have SARS-CoV-2 infection rates of up to 40% – shed and transmit the virus for up to five days once infected, according to a new study.
Home health care workers often suffer from poorer physical and mental health, when compared with similar low-wage frontline workers, according to new research by Weill Cornell Medicine.
Meiogenix, a next-generation technology startup that helps agricultural crops find their own genetic solutions, via chromosome editing, has joined Cornell’s McGovern Center incubator.
A new Cornell study sheds light on a controversial debate in epigenetics – the set of molecular changes occurring on top of the genome that regulate how genes are turned on and off, but without changing a cell’s DNA sequence.
Adam Seth Litwin, an expert on issues involving technological change, work and workers in the healthcare sector, says because frontline caregivers are in such high demand, the healthcare sector may need to rely on prevention instead of treatment.
